Array Instruments Market Report by Application (Molecular Biology, Cell Biology, Genetics, Molecular Pathology, and Others), Technology (DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays), End-User (Research and Development La

Array Instruments Market Report by Application (Molecular Biology, Cell Biology, Genetics, Molecular Pathology, and Others), Technology (DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays), End-User (Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Veterinary Laboratories, Forensic Centers, and Others), and Region 2024-2032


The global array instruments market size reached US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1.6 Billion by 2032, exhibiting a growth rate (CAGR) of 3.6% during 2024-2032.

An array instrument is used in laboratories for quantitatively and simultaneously monitoring the expression of multiple genes. It contains numerous small representative tissue samples from hundreds of different cases, which are assembled on a single histologic slide. The high-throughput approach of the array instrument aids in locating chromosomal expressions and mutations in a genotype, as well as measuring and detecting gene expressions at the messenger RNA (mRNA) or protein level. As a result, it finds applications in molecular and cell biology, genetics, molecular pathology, and for synthesizing and sequencing nucleic acids.

The increasing prevalence of chronic diseases, in confluence with the emerging need for their early detection and diagnosis, represents one of the key factors driving the global array instruments market growth. In addition to this, governments of several countries are investing in the improvement of healthcare facilities, which in turn, is positively influencing the demand for array instruments, especially in emerging economies. Furthermore, these instruments can be incorporated with a wide range of technologies, owing to which they find applications in different areas of research, such as life sciences and drug discovery. For instance, deoxyribonucleic acid (DNA) microarrays are used for examining changes in gene expression by fluorescent labeling of complementary DNA, whereas tissue microarrays aid in identifying new diagnostic and prognostic markers and targeting cancer in human beings. Other than this, the introduction of advanced technologies, such as microarray-based comparative genomic hybridization (array CGH), is expected to bolster the market growth in the upcoming years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global array instruments market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application, technology and end-user.

Breakup by Application:

Molecular Biology
Cell Biology
Genetics
Molecular Pathology
Others

Breakup by Technology:

DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays

Breakup by End-User:

Research and Development Laboratories
Clinical Diagnostic Labs
Agriculture Research Centers
Veterinary Laboratories
Forensic Centers
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Affymetrix Inc., Agilent Technologies Inc., Arrayit Corporation, Bio-RAD Laboratories, Inc. Illumina Inc., Laboratory Corporation, Molecular Devices LLC, Raybiotech Inc., Sigma Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:
How has the global array instruments market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global array instruments market?
What is the breakup of the market based on the application?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global array instruments market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Array Instruments Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Application
6.1 Molecular Biology
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cell Biology
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Genetics
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Molecular Pathology
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Technology
7.1 DNA Microarrays
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Protein Microarrays
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cellular Microarrays
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Tissue Microarrays
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End-User
8.1 Research and Development Laboratories
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinical Diagnostic Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Agriculture Research Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Veterinary Laboratories
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Forensic Centers
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Affymetrix Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Agilent Technologies Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Arrayit Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Bio-RAD Laboratories Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Illumina Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Laboratory Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Molecular Devices LLC
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Raybiotech Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sigma Aldrich Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Thermo Fisher Scientific Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings